Brussels, Belgium

Michel Hamende


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Uccle, BE (2000)
  • Brussels, BE (2003 - 2007)

Company Filing History:


Years Active: 2000-2007

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michel Hamende

Introduction

Michel Hamende is a prominent inventor based in Brussels, Belgium, recognized for his innovative contributions in the field of pharmaceuticals. With a portfolio that includes six patents, he has made significant strides in chemical processes that enhance drug development and formulation.

Latest Patents

Among his latest achievements are his patents relating to the process for preparing (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide. These inventions describe a meticulous process for the separation of a racemic mixture utilizing multiple column chromatography, providing a critical advancement in the preparation of these compounds for pharmaceutical applications.

Career Highlights

Throughout his career, Michel has worked with esteemed companies in the pharmaceutical industry, such as UCB S.A. and Novasep. His work in these organizations has allowed him to hone his skills and contribute to pioneering projects, ultimately leading to his successful patent filings.

Collaborations

Michel has collaborated with notable professionals in his field, including his coworkers Emile Cavoy and Vincent Zimmermann. These partnerships have facilitated the sharing of knowledge and expertise, further enhancing the innovative nature of his work.

Conclusion

Michel Hamende's contributions to invention and innovation, particularly in pharmaceutical processes, underscore his importance as an inventor. His patents not only highlight his creativity and technical skill but also reflect the potential of his work to impact the pharmaceutical industry positively. As he continues to innovate, the scientific community eagerly anticipates his future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…